# Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy

> **NCT02984813** · PHASE1 · TERMINATED · sponsor: **The New York Eye & Ear Infirmary** · enrollment: 21 (actual)

## Conditions studied

- Open-angle Glaucoma
- Diabetic Retinopathy

## Interventions

- **DRUG:** GlaucoHealth
- **DRUG:** GlaucoSelect
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02984813
- **Lead sponsor:** The New York Eye & Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-15
- **Primary completion:** 2017-01-15
- **Final completion:** 2017-01-15
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Investigator left the institution
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02984813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02984813, "Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02984813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*